Bioceros is one of Europe’s premier providers of services related to the preclinical development of monoclonal antibodies and generation of GMP-ready protein producing cell lines (CHO, PER.C6® and Potelligent®). 


We have state of the art facilities in the Alexander Numan building at the Science Park Utrecht, the Netherlands. Currently, Bioceros serves clients from the Netherlands, USA, United Kingdom, Australia, Scandinavia, Korea, Russia and more. We also use our validated technology platform and preclinical development expertise to design and develop effective proprietary therapeutic monoclonal antibodies.